Restrictions for Medicaid reimbursement of sofosbuvir for the treatment of hepatitis C virus infection in the United States
The aim of this study was to systematically evaluate state Medicaid policies for the treatment
of hepatitis C virus (HCV) infection with sofosbuvir in the United States. Medicaid …
of hepatitis C virus (HCV) infection with sofosbuvir in the United States. Medicaid …
Long-term treatment outcomes of patients infected with hepatitis C virus: a systematic review and meta-analysis of the survival benefit of achieving a sustained …
Background. Achievement of a sustained virologic response (SVR) after treatment for
Hepatitis C infection is associated with improved outcomes. This meta-analysis aimed to …
Hepatitis C infection is associated with improved outcomes. This meta-analysis aimed to …
[ΒΙΒΛΙΟ][B] Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach-2010 revision
World Health Organization - 2010 - apps.who.int
ISBN 978 92 4 459976 1(NLM classification: WC 503.2)© всемирная организация
здравоохранения, 2010 г. все права защищены. публикации всемирной организации …
здравоохранения, 2010 г. все права защищены. публикации всемирной организации …
[HTML][HTML] Hepatitis C virus: Morphogenesis, infection and therapy
Hepatitis C virus (HCV) is a major cause of liver diseases including liver cirrhosis and
hepatocellular carcinoma. Approximately 3% of the world population is infected with HCV …
hepatocellular carcinoma. Approximately 3% of the world population is infected with HCV …
Causes of death among HIV-infected patients in France in 2010 (national survey): trends since 2000
P Morlat, C Roussillon, S Henard, D Salmon, F Bonnet… - Aids, 2014 - journals.lww.com
Objective: The Mortalité 2010 survey aimed at describing the causes of death among HIV-
infected patients in France in 2010 and their evolution since 2000. Design and methods: A …
infected patients in France in 2010 and their evolution since 2000. Design and methods: A …
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort …
Collaboration of Observational HIV … - International journal …, 2012 - academic.oup.com
Background Using data from a large European collaborative study, we aimed to identify the
circumstances in which treated HIV-infected individuals will experience similar mortality …
circumstances in which treated HIV-infected individuals will experience similar mortality …
Recommendations for the management of hepatitis C virus infection among people who inject drugs
In high income countries, the majority of new and existing hepatitis C virus (HCV) infections
occur among people who inject drugs (PWID). In many low and middle income countries …
occur among people who inject drugs (PWID). In many low and middle income countries …
HCV and HIV co-infection: mechanisms and management
HCV and HIV co-infection is associated with accelerated hepatic fibrosis progression and
higher rates of liver decompensation and death compared to HCV monoinfection, and liver …
higher rates of liver decompensation and death compared to HCV monoinfection, and liver …
HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies
EA Operskalski, A Kovacs - Current HIV/AIDS Reports, 2011 - Springer
World-wide, hepatitis C virus (HCV) accounts for approximately 130 million chronic
infections, with an overall 3% prevalence. Four to 5 million persons are co-infected with HIV …
infections, with an overall 3% prevalence. Four to 5 million persons are co-infected with HIV …
Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV
Context Human immunodeficiency virus (HIV) accelerates hepatitis C virus (HCV) disease
progression; however, the effect of liver disease stage and antiviral therapy on the risk of …
progression; however, the effect of liver disease stage and antiviral therapy on the risk of …